Internal Medicine, Nephrology · Lafayette, LA
NPI
1124037726
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
2804 Ambassador Caffery Pkwy
Lafayette, LA, 70506
Phone (337) 981-5156
Groups this clinician bills Medicare through
Medicare paid, 2024
$294K
3,306 services
Medicare patients, 2024
609
Average age 73
Drug cost, 2024
$1.4M
3,220 prescriptions
Company payments, 2025
$9,965
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anthony P Blalock was code 99232 (hospital e&m - subsequent), 920 times for 312 patients. In total Anthony P Blalock billed 3,306 services in 24 codes, and Medicare paid $294K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 920 | 312 | $57.81 | $53K |
| 90960 ESRD Related Services (not dialysis) | Office | 435 | 68 | $261.92 | $114K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 418 | 179 | $11.91 | $4,980 |
| 99214 Office E&M - Established | Office | 393 | 173 | $68.81 | $27K |
| 99222 Hospital E&M - Initial | Facility | 275 | 233 | $94.55 | $26K |
| 99231 Hospital E&M - Subsequent | Facility | 211 | 123 | $35.40 | $7,470 |
| 90961 ESRD Related Services (not dialysis) | Office | 138 | 64 | $215.04 | $30K |
| 90935 Hemodialysis | Facility | 110 | 74 | $52.53 | $5,779 |
| 90970 ESRD Related Services (not dialysis) | Office | 99 | 11 | $7.00 | $693 |
| 99233 Hospital E&M - Subsequent | Facility | 80 | 59 | $86.84 | $6,948 |
| 99213 Office E&M - Established | Office | 36 | 31 | $47.88 | $1,724 |
| 99223 Hospital E&M - Initial | Facility | 32 | 32 | $129.27 | $4,137 |
| 99215 Office E&M - Established | Office | 30 | 21 | $78.20 | $2,346 |
| 81003 Clinical Chemistry | Office | 26 | 26 | $2.20 | $57.2 |
| 82570 Clinical Chemistry | Office | 26 | 26 | $5.08 | $132 |
By year: 2022 $253K for 2,692 services; 2023 $261K for 3,046 services; 2024 $294K for 3,306 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 26 | 26 | $2.20 | $57.2 |
| 82570 Clinical Chemistry | 26 | 26 | $5.08 | $132 |
Medicare prescription drug claims, 2024
In 2024, the drug Anthony P Blalock prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 470 prescriptions and refills. In total Anthony P Blalock wrote 3,220 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 470 | 557 | 77 | $296K |
| Lokelma Sodium Zirconium Cyclosilicate | 307 | 475 | 71 | $219K |
| Ramipril Generic | 275 | 461 | 60 | $2,122 |
| Amlodipine Besylate Generic | 266 | 504 | 77 | $1,756 |
| Sevelamer Carbonate Generic | 256 | 336 | 63 | $35K |
| Clonidine Generic | 180 | 268 | 40 | $18K |
| Auryxia Ferric Citrate | 111 | 161 | 22 | $289K |
| Velphoro Sucroferric Oxyhydroxide | 103 | 111 | 21 | $346K |
| Furosemide Generic | 75 | 134 | 25 | $409 |
| Carvedilol Generic | 75 | 119 | 20 | $273 |
| Nifedipine Er Nifedipine | 60 | 86 | 18 | $1,085 |
| Clonidine Hcl Generic | 57 | 85 | 11 | $540 |
| Losartan Potassium Generic | 54 | 109 | 16 | $380 |
| Torsemide Generic | 49 | 58 | 16 | $615 |
| Potassium Chloride Generic | 43 | 55 | Under 11 | $550 |
Brand drugs: 1,093 claims; generic drugs: 2,127 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anthony P Blalock $9,965 ($9,965 in general payments such as food, travel and fees) from 2 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $9,787.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 14 | $9,787 |
| Coloplast Corp | 1 | $178 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.